TWD 51.5
(-2.83%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 1.1 Billion TWD | 517.45% |
2022 | 178.96 Million TWD | 544.38% |
2021 | 27.77 Million TWD | 1.22% |
2020 | 27.43 Million TWD | -45.92% |
2019 | 50.73 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 215.24 Million TWD | -0.84% |
2024 Q1 | 217.06 Million TWD | -27.57% |
2023 Q1 | 330.92 Million TWD | 121.93% |
2023 FY | 1.1 Billion TWD | 517.45% |
2023 Q4 | 299.68 Million TWD | 25.04% |
2023 Q3 | 239.68 Million TWD | 2.11% |
2023 Q2 | 234.72 Million TWD | -29.07% |
2022 FY | 178.96 Million TWD | 544.38% |
2022 Q4 | 149.11 Million TWD | 0.0% |
2021 FY | 27.77 Million TWD | 1.22% |
2020 FY | 27.43 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Allied Biotech Corporation | 246.43 Million TWD | -348.395% |
GeneFerm Biotechnology Co., Ltd. | 286.35 Million TWD | -285.897% |
Easywell Biomedicals, Inc. | 170.71 Million TWD | -547.277% |
TTY Biopharm Company Limited | 3.22 Billion TWD | 65.722% |
Synmosa Biopharma Corporation | 2.11 Billion TWD | 47.875% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 48.537% |
Center Laboratories, Inc. | 618.09 Million TWD | -78.778% |
Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | -286.17% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | -135.779% |
InnoPharmax Inc. | 17.45 Million TWD | -6229.948% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -351.705% |
Excelsior Biopharma Inc. | 306.93 Million TWD | -260.023% |
DV Biomed Co., Ltd. | 764.27 Million TWD | -44.584% |
Foresee Pharmaceuticals Co., Ltd. | 113.97 Million TWD | -869.553% |
UniPharma Co., Ltd. | 51.01 Million TWD | -2066.024% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | -178.389% |
Alar Pharmaceuticals Inc. | 465.92 Million TWD | -137.169% |
Winston Medical Supply Co., Ltd. | 347.59 Million TWD | -217.901% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -186558.615% |
Bioray Biotech Co., Ltd | 77.65 Million TWD | -1323.058% |
TSH Biopharm Corporation Limited | 399.89 Million TWD | -176.325% |